ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Inhibrx Biosciences Inc

Inhibrx Biosciences Inc (INXB)

15.86
0.00
(0.00%)
Closed 20 April 6:00AM
0.00
0.00
(0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 0100k0100k
Operating Income -49.21M-185.51M-46.8M-49.93M
Pre Tax Income -49.27M1.83B-43.86M-47.87M
Net Income -49.27M1.83B-43.86M-47.87M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) 0000
EBIT -49.27M1.84B-46.78M-49.87M
EBITDA -48.85M-185.03M-46.04M-49.24M
Year End 31 December 2024 202220232024
USD (US$)USD (US$)USD (US$)
Total Revenue 1.32M1.63M200k
Operating Income -115.32M-152.75M-331.45M
Pre Tax Income -115.32M-154.96M1.69B
Net Income -115.33M-154.96M1.69B
Preferred Dividends 000
Basic Earnings Per Share (EPS) -47.071-63.251116.577
EBIT -115.32M-153.33M1.69B
EBITDA -114.1M-151.56M-329.16M